Yaron Daniely

Yaron Daniely

Chief Executive Officer at Yissum Research Development Co. Ltd.

48 year
Health Technology
Consumer Services
Finance

Profile

Yaron Daniely is currently the President & Chief Executive Officer at Yissum Research Development Co. Ltd.
and a Member at the American Society of Hematology.
He is also a General Partner at aMoon Ventures Y Sh Ltd.
Dr. Daniely previously served as the President & CEO of Starlet Derma Ltd.
and NanoCyte Ltd.
He was also a Director at Alcobra Ltd., Bioblast Pharma Ltd., and Integra Holdings Ltd.
Additionally, he was a Member of the National Institutes of Health and the Weizmann Institute of Science.
Dr. Daniely started his career as the Vice President-Business Development at Gamida Cell Ltd.
He holds an undergraduate degree from Florida International University, an MBA from Technion-Israel Institute of Technology, and a doctorate from New York University School of Medicine.

Yaron Daniely active positions

CompaniesPositionStart
Corporate Officer/Principal -
Chief Executive Officer -
Private Equity Investor 2019-10-31
All active positions of Yaron Daniely

Former positions of Yaron Daniely

CompaniesPositionEnd
Chief Executive Officer 2010-04-30
Chief Executive Officer 2010-01-01
GAMIDA CELL LTD. Corporate Officer/Principal -
Director/Board Member -
Director/Board Member -
See the detail of Yaron Daniely's experience

Training of Yaron Daniely

Florida International University Undergraduate Degree
Technion-Israel Institute of Technology Masters Business Admin
New York University School of Medicine Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Yaron Daniely's experience

Connections

100 +

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
GAMIDA CELL LTD.

Health Technology

Private companies9

Commercial Services

Government

Health Technology

Health Technology

Health Technology

Miscellaneous

Finance

Finance

Health Technology

See company connections
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW